Which ASX companies are resurrecting abandoned drugs? Part 3
Several ASX companies are repurposing or resurrecting abandoned or under utilised drugs Paradigm Biopharmaceuticals identified the potential of FDA-approved PPS that has a long track [more…]
Weed Week: A VAST majority of Americans now want marijuana to be legal
Where are we in terms of US legalisation of cannabis? What about the current legal landscape for cannabis in Australia? We look at the best [more…]
There’s a graphene called ‘goldene’ and it could enable gold semiconductors to make green hydrogen
Researchers in Sweden have cracked the code to making goldene, which is just like graphene, except it’s made from gold – and it has the [more…]
Aussie capital city listings down 8.5pc on last year: PropTrack
Less homes, more buyers is the grim takeout from PropTrack’s latest analysis of property listings from around the country. New homes for sale on the [more…]
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to 18 April, 2024 – an important date in the history of everything, for a variety of rapidly-cobbled together [more…]
Neurotech’s Phase 2/3 autism trial meets primary endpoint
Neurotech Phase 2/3 NTIASD trial in autism spectrum disorder meets primary endpoint Study showed a statistically significant improvement in severity of illness in paediatric patients [more…]
Long Shortz with Maronan Metals: Metallurgy serves success on a silver platter
Stockhead’s Sarah Hughan sits down with Maronan Metals (ASX:MMA) managing director Richard Carlton to get the short end of the long story on the company’s latest [more…]
Challenges Ahead: Sheila Bair on Regional Bank Vulnerabilities
As regional banks prepare to unveil their quarterly earnings, concerns loom about potential vulnerabilities within the sector. Sheila Bair, the former U.S. Federal Deposit Insurance [more…]
Whistleblower Expresses Concerns Over Boeing 787’s Safety at Senate Hearing
Boeing is poised to confront severe criticism at an upcoming US Senate hearing, where whistleblower and engineer Sam Salehpour will testify against the aerospace giant’s [more…]
Monsters of Rock: EVN in a race to meet ambitious gold targets but with prices where they are does it even matter?
Evolution continues to believe it can meet an ambitious gold target despite needing to produce at a near million ounce run rate in the [more…]
